An update on the human and animal enteric pathogen Clostridium perfringens

Raymond Kiu, Lindsay J. Hall

Research output: Contribution to journalArticlepeer-review

101 Citations (Scopus)
18 Downloads (Pure)

Abstract

Clostridium perfringens, a rapid-growing pathogen known to secrete an arsenal of >20 virulent toxins, has been associated with intestinal diseases in both animals and humans throughout the past century. Recent advances in genomic analysis and experimental systems make it timely to re-visit this clinically and veterinary important pathogen. This Review will summarise our understanding of the genomics and virulence-linked factors, including antimicrobial potentials and secreted toxins of this gut pathogen, and then its up-to-date clinical epidemiology and biological role in the pathogenesis of several important human and animal-associated intestinal diseases, including pre-term necrotising enterocolitis. Finally, we highlight some of the important unresolved questions in relation to C. perfringens-mediated infections, and implications for future research directions.
Original languageEnglish
Article number141
JournalEmerging Microbes & Infections
Volume7
DOIs
Publication statusPublished - 6 Aug 2018

Cite this